Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma [Phase 2]
This is a Phase 2 clinical trial update evaluating the T-CID regimen (thalidomide, cyclophosphamide, oral idarubicin, and dexamethasone) in …
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder [Phase 1]
This Phase 1 trial evaluating 12-O-tetradecanoylphorbol-13-acetate in hematologic cancers and bone marrow disorders was terminated.
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy [Phase 3]
Phase 3 trial assessing the efficacy and safety of aprepitant in multiple myeloma patients during and after high-dose chemotherapy.
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma [Phase 1]
A Phase 1 trial evaluating dendritic cell/tumor fusion vaccines as a novel immunotherapy for multiple myeloma has completed the study.
-
CLINICAL_TRIALS trial_result · 2009-12-14Clinical Trial Update: A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma [Phase 2]
Phase 2 study evaluating Aplidin (plitidepsin) given as a 3-hour IV infusion in relapsed or refractory multiple myeloma has completed, with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-11-23Clinical Trial Update: Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma [Phase 3]
A Phase 3 clinical trial update evaluating the efficacy and safety of zoledronic acid in patients with bone metastases from solid tumors or …
-
CLINICAL_TRIALS trial_result · 2009-11-16Clinical Trial Update: Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
This update reports on a completed trial comparing piperacillin-tazobactam alone versus with a glycopeptide in neutropenic patients with hem…
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma [Phase 1]
This ClinicalTrials.gov record reports a completed Phase 1 trial evaluating a dendritic cell-based idiotype vaccination in Stage I multiple …
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma [Phase 1]
A Phase I, multi-center, open-label dose-escalation study of HuLuc63 in subjects with advanced multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma [Phase 2]
Phase II study comparing continuous versus syncopated dosing of CC-5013 (lenalidomide) for refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: GEM05 for Patients With Multiple Myeloma Under 65 Years [Phase 3]
A Phase 3 clinical trial named GEM05 for patients with multiple myeloma under 65 years has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma [Phase 2]
This is a Phase 2 trial evaluating Velcade (bortezomib) in combination with dexamethasone for multiple myeloma, which has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating an idiotype-pulsed allogeneic dendritic cell vaccine for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients [Phase 1, Phase 2]
A Phase 1/2 safety and efficacy study of Imexon in multiple myeloma has completed, reporting the trial results.
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) [Phase 2]
Phase 2 clinical trial evaluating treosulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation, focusing on saf…
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating the RAD combination (lenalidomide, doxorubicin, dexamethasone) in relapsed or refractory multiple myeloma h…
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients [Phase 3]
Phase 3 trial comparing high-dose versus standard-dose melphalan in newly diagnosed multiple myeloma patients has completed enrollment with …
-
CLINICAL_TRIALS trial_result · 2009-07-14Clinical Trial Update: Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients [Phase 1, Phase 2]
A Phase 1/2 trial evaluating arsenic trioxide in combination with ascorbic acid and melphalan in patients with multiple myeloma has complete…
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer) [Phase 2]
A Phase 2 clinical trial updates on the efficacy of Velcade (bortezomib) for bone tissue outcomes in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma [Phase 3]
Phase 3 clinical trial evaluating the incidence of febrile episodes during stem cell collection after chemotherapy in multiple myeloma patie…
-
CLINICAL_TRIALS trial_result · 2009-05-29Clinical Trial Update: Serum Free Light Change in Multiple Myeloma
An update on a clinical trial investigating changes in serum free light chains in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2009-05-28Clinical Trial Update: Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma [Phase 2]
This release reports results from a completed Phase 2 trial evaluating dose-reduced allogeneic stem cell transplantation after autologous hi…
-
CLINICAL_TRIALS trial_result · 2009-05-11Clinical Trial Update: Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies [Phase 2]
Phase 2 clinical trial update examining chemotherapy-related anemia in patients with non-myeloid malignancies has been completed.
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
This document reports on a Phase 1/2 clinical trial evaluating Holmium-166 DOTMP chemotherapy combined with peripheral stem cell transplanta…
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients [Phase 3]
A Phase 3 clinical trial evaluating bortezomib-induced peripheral neuropathy in patients with multiple myeloma; the project status is curren…